Mangoceuticals MGRX 深 滬
等待開盤 10-08 09:30:00 美东时间
0.4437
-0.006
-1.40%
華盛通- 最 高0.4782
- 今 開0.4326
- 成交量 64.61万股
- 最 低 0.4302
- 昨 收 0.45
- 總市值 956.95万
- 52周最高 2.75
- 市盈率 靜 --
- 換手率 3.00%
- 52周最低 0.162
- 委 比 50.00%
- 總股本 2156.74万
- 歷史最高 65.55
- 量 比 0.70
- 振 幅 10.67%
- 歷史最低 0.162
- 每 手 1
- 風險率 0.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Nike Inc. (NYSE:NKE) reported mixed first-quarter financial results. Nike reported first-quarter revenue of $11.21 billion, missing analyst estimates of $11.33 billion...
10-02 16:16
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why
Mangoceuticals, Inc. (NASDAQ:MGRX) shares fell 12.24% to $0.42 in after-hours trading Thursday after the company announced its former subsidiary secured a $2.5 million strategic investment. Mangoceuticals develops and sells health and wellness products through a telemedicine platform under the Mango...
10-02 13:22
Mangoceuticals’ MangoRx IP Secures $2.5M Investment From Strategic Investors, Receives Initial $1.75M Tranche
Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company’s Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock DALLAS, TEXAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("Mangoceuticals" or the "Company"), a compan...
10-02 03:52
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche
Mangoceuticals subsidiary MangoRx IP Holdings secures $2.5 million investment from strategic investors, with $1.75 million received as initial tranche. The investment, structured at the subsidiary level, avoids issuing any MGRX common stock, preserving the Company’s capital structure. Funds will support commercialization of antiviral intellectual property, targeting oral care and feed additives markets valued at $34.8 billion and $39.8 billion re...
10-01 19:50
Mangoceuticals Terminates Planned Business Combination with Nuclea
Mangoceuticals, Inc. ( ($MGRX) ) has provided an update. On August 19, 2026, Ma...
08-22 06:02
On Aug 19, Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement; Pipe Financing Minimum Of $15M Not Raised By Aug 21, 2026; Closing Conditions Not Met
On August 19, 2026, Mangoceuticals, Inc. (the "Company" or "MGRX") and Nuclea Energy Inc. ("Nuclea") mutually agreed to terminate that certain Business Combination Agreement, dated as of July 29, 2026 (the "BCA"), among the Company, Nuclea, and the Principal Nuclea Shareholders and Mango Principals ...
08-22 05:19
12 Consumer Staples Stocks Moving In Thursday's After-Market Session
Gainers Mangoceuticals (NASDAQ:MGRX) shares increased by 40.0% to $0.75 during Thursday's after-market session. The company's market cap stands at $9.1 million. Laird Superfood (AMEX:LSF) shares moved upwards by 11.88% to $4.9. The company's market cap stands at $46.7 million. As per the press relea...
08-14 05:06
Mangoceuticals shares are trading higher after the company announced its merger partner, Nuclea Energy, entered into a definitive agreement to acquire Moltex Energy nuclear technology assets.
Mangoceuticals shares are trading higher after the company announced its merger partner, Nuclea Energy, entered into a definitive agreement to acquire Moltex Energy nuclear technology assets.
08-14 04:31
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
Mangoceuticals announced that its subsidiary, Nuclea Energy, has entered into a definitive agreement to acquire advanced nuclear technology assets from Moltex Energy, including the SSR-W reactor and WATSS spent fuel recycling technology. The acquisition, valued at over C$96 million, aims to expand Nuclea's nuclear technology portfolio and strengthen its position in the advanced nuclear sector. The transaction is structured as an asset purchase an...
08-13 20:05
11 Consumer Staples Stocks Moving In Monday's After-Market Session
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came out today. Andersons (NASDAQ:ANDE) stock moved upwards by 10.22% to $77.0. The company's market cap ...
08-04 05:05
